Differential/JJ
nuclear/JJ
localization/NN
of/IN
p50/NN
,/,
p52/NN
,/,
and/CC
RelB/NN
proteins/NNS
in/IN
human/JJ
accessory/JJ
cells/NNS
of/IN
the/DT
immune/JJ
response/NN
in/FW
situ/FW
./.

The/DT
Rel/NF-kappa/NN
B/NN
proteins/NNS
,/,
p50/NN
,/,
p52/NN
,/,
p65/NN
,/,
c-Rel/NN
,/,
and/CC
RelB/NN
,/,
constitute/VBP
a/DT
family/NN
of/IN
transcription/NN
factors/NNS
involved/VBN
in/IN
the/DT
positive/JJ
regulation/NN
of/IN
a/DT
variety/NN
of/IN
genes/NNS
during/IN
the/DT
immune/JJ
response/NN
./.
=====
Recently/RB
,/,
it/PRP
has/VBZ
been/VBN
shown/VBN
that/IN
RelB/NN
knockout/JJ|NN
mice/NNS
have/VBP
no/DT
dendritic/JJ
cells/NNS
(/(
DC/NN
)/)
./.
=====
An/DT
overexpression/NN
of/IN
p50/NN
has/VBZ
been/VBN
described/VBN
in/IN
follicular/JJ
dendritic/JJ
cells/NNS
(/(
FDC/NN
)/)
./.
=====
A/DT
constitutive/JJ
NF-kappa/NN
B/NN
activity/NN
has/VBZ
been/VBN
reported/VBN
in/IN
mature/JJ
macrophages/NNS
./.
=====
This/DT
led/VBD
to/TO
the/DT
hypothesis/NN
that/IN
some/DT
of/IN
the/DT
Rel/NF-kappa/NN
B/NN
proteins/NNS
were/VBD
key/JJ
nuclear/JJ
factors/NNS
in/IN
functions/NNS
of/IN
accessory/JJ
cells/NNS
of/IN
the/DT
immune/JJ
response/NN
./.
=====
Therefore/RB
,/,
we/PRP
investigated/VBD
in/FW
situ/FW
the/DT
nuclear/JJ
localization/NN
of/IN
Rel/NF-kappa/NN
B/NN
proteins/NNS
in/IN
accessory/JJ
cells/NNS
of/IN
the/DT
immune/JJ
system/NN
by/IN
immunohistochemistry/NN
and/CC
double/JJ
labeling/NN
by/IN
immunofluorescence/NN
from/IN
five/CD
normal/JJ
human/JJ
tonsils/NNS
and/CC
five/CD
lymph/NN
nodes/NNS
with/IN
follicular/JJ
hyperplasia/NN
./.
=====
Nuclear/JJ
p65/NN
and/CC
c-Rel/NN
proteins/NNS
were/VBD
found/VBN
in/IN
all/DT
cell/NN
types/NNS
including/VBG
lymphocytes/NNS
./.
=====
In/IN
germinal/JJ
centers/NNS
GC/NN
,/,
p50/NN
,/,
p52/NN
,/,
and/CC
RelB/NN
were/VBD
found/VBN
in/IN
the/DT
nuclei/NNS
of/IN
FDC/NN
only/RB
and/CC
were/VBD
not/RB
detected/VBN
in/IN
the/DT
nuclei/NNS
of/IN
CD68+/JJ
cells/NNS
./.
=====
In/IN
T/NN
cell/NN
areas/NNS
,/,
p50/NN
,/,
p52/NN
,/,
and/CC
RelB/NN
were/VBD
found/VBN
in/IN
the/DT
nuclei/NNS
of/IN
HLA-DR+/JJ
cells/NNS
with/IN
an/DT
antigen-presenting/JJ
cell/NN
(/(
APC/NN
)/)
morphology/NN
./.
=====
p52/NN
and/CC
RelB/NN
were/VBD
detected/VBN
in/IN
the/DT
nuclei/NNS
in/IN
both/CC
CD1a+/JJ
and/CC
CD68+/JJ
cells/NNS
from/IN
the/DT
T/NN
cell/NN
area/NN
,/,
whereas/IN
p50/NN
was/VBD
found/VBN
only/RB
in/IN
CD68-/JJ
and/CC
CD1a-cells/NNS
./.
=====
Cells/NNS
with/IN
nuclear/JJ
p50/NN
were/VBD
negative/JJ
for/IN
the/DT
CD38/NN
,/,
CD20/NN
and/CC
CD2/NN
markers/NNS
./.
=====
These/DT
results/NNS
show/VBP
that/IN
,/,
physiologically/RB
,/,
high/JJ
levels/NNS
of/IN
nuclear/JJ
of/IN
p50/NN
,/,
p52/NN
and/CC
RelB/NN
are/VBP
restricted/JJ
to/TO
accessory/JJ
cells/NNS
of/IN
the/DT
immune/JJ
system/NN
,/,
which/WDT
include/VBP
FDC/NN
in/IN
GC/NN
,/,
and/CC
DC/NN
and/CC
macrophages/NNS
in/IN
the/DT
T/NN
cell/NN
zone/NN
,/,
that/IN
specialized/VBN
scavenger/NN
macrophages/NNS
from/IN
GC/NN
do/VBP
not/RB
have/VB
detectable/JJ
levels/NNS
of/IN
p52/NN
and/CC
RelB/NN
,/,
whereas/IN
macrophages/NNS
from/IN
the/DT
T/NN
cell/NN
area/NN
,/,
known/VBN
to/TO
present/VB
the/DT
antigen/NN
to/TO
T/NN
cells/NNS
,/,
do/VBP
have/VB
both/CC
nuclear/JJ
p52/NN
and/CC
RelB/NN
,/,
and/CC
that/IN
in/IN
the/DT
T/NN
cell/NN
zone/NN
,/,
p52/NN
and/CC
RelB/NN
are/VBP
located/JJ
in/IN
nuclei/NNS
of/IN
both/DT
CD1a+/JJ
,/,
CD68+/JJ
or/CC
both/DT
,/,
cells/NNS
APC/NN
,/,
whereas/IN
p50/NN
is/VBZ
restricted/JJ
to/TO
CD1a-/NN
and/CC
CD68- APC/NN
./.
=====
The/DT
different/JJ
patterns/NNS
of/IN
p50/NN
,/,
p52/NN
and/CC
RelB/NN
protein/NN
nuclear/JJ
localization/NN
may/MD
provide/VB
insight/NN
into/IN
their/PRP$
different/JJ
roles/NNS
during/IN
the/DT
immune/JJ
response/NN
in/FW
vivo/FW
./.